Sandu Pharmaceuticals Ltd

₹ 62.4 2.28%

03 May - close price

About

Incorporated in 1985, Sandu Pharmaceuticals Ltd manufactures and trades Ayurvedic proprietary medicines.

Key Points

Product Portfolio:^[1]
Company manufactures over 100 types of products, including oils, syrups, granules, powder, and avlehas, which are marketed under the Sandu brand viz, Sandu Ashoka Compound, Sandu Abhayarishta, Sandu Arvindasav, Sandu Balant Kadha No. 1, Sandu Debix Tablet, Sandu Bhunimbadi Kadha, Sandu Chandanasav Syrup, Sandu Chandraprabha, Sandu Chyavanprash Special, Sandu Dadimavaleha, etc.

Website BSE

Market Cap ₹ 60.3 Cr.
Current Price ₹ 62.4
High / Low ₹ 85.0 / 49.0
Stock P/E 52.9
Book Value ₹ 41.7
Dividend Yield 1.20 %
ROCE %
ROE 4.02 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	17.59	19.15	11.42	16.23	16.76	17.09	15.26	17.66	16.61	17.43
	16.79	18.38	10.85	15.91	15.90	16.27	14.77	17.31	15.79	16.92
Operating Profit	0.80	0.77	0.57	0.32	0.86	0.82	0.49	0.35	0.82	0.51
OPM %	4.55%	4.02%	4.99%	1.97%	5.13%	4.80%	3.21%	1.98%	4.94%	2.93%
	0.03	0.00	0.03	0.09	0.17	0.03	0.04	0.00	0.09	0.03
Interest	0.05	0.00	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.02
Depreciation	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.12	0.13	0.14
Profit before tax	0.65	0.64	0.45	0.26	0.88	0.70	0.38	0.21	0.77	0.38
Tax %	30.77%	29.69%	40.00%	34.62%	31.82%	30.00%	26.32%	47.62%	27.27%	44.74%
	0.45	0.45	0.27	0.17	0.60	0.48	0.27	0.11	0.55	0.21
EPS in Rs	0.57	0.57	0.31	0.19	0.62	0.50	0.28	0.11	0.57	0.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	TTM
	65.50	65.35	66.96
	62.62	62.87	64.79
Operating Profit	2.88	2.48	2.17
OPM %	4.40%	3.79%	3.24%
	0.08	0.33	0.16
Interest	0.11	0.08	0.07
Depreciation	0.53	0.52	0.52
Profit before tax	2.32	2.21	1.74
Tax %	31.47%	31.22%
	1.59	1.52	1.14
EPS in Rs	1.80	1.57	1.18
Dividend Payout %	41.56%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	9%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-25%

Stock Price CAGR
10 Years:	21%
5 Years:	24%
3 Years:	12%
1 Year:	9%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Sep 2023
Equity Capital	8.81	9.66	9.66
Reserves	27.66	29.58	30.60
	0.00	0.00	0.00
	12.81	14.93	12.66
Total Liabilities	49.28	54.17	52.92
	16.00	16.62	16.72
CWIP	0.48	0.42	0.67
Investments	9.11	9.65	10.03
	23.69	27.48	25.50
Total Assets	49.28	54.17	52.92

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023
	0.95	0.22
	-5.47	0.54
	0.93	0.58
Net Cash Flow	-3.59	1.34

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023
Debtor Days	22.23	26.75
Inventory Days	115.06	167.70
Days Payable	69.63	98.30
Cash Conversion Cycle	67.67	96.15
Working Capital Days	42.41	52.33
ROCE %

Shareholding Pattern

Numbers in percentages

2 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	45.04%	45.04%	48.02%	50.43%	50.43%	50.43%	50.43%	52.42%	52.42%	42.91%	42.91%	42.91%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	54.95%	54.95%	51.97%	49.56%	49.56%	49.56%	49.55%	47.59%	47.58%	57.10%	57.10%	57.09%
No. of Shareholders	10,108	10,508	10,374	10,386	10,320	10,228	10,264	10,141	10,121	10,103	10,021	10,001

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	44.99%	44.99%	44.99%	44.99%	45.04%	50.43%	52.42%	42.91%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	55.00%	55.00%	55.00%	55.00%	54.95%	49.56%	47.59%	57.09%
No. of Shareholders	10,590	10,152	10,037	9,901	9,670	10,386	10,141	10,001

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings